The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksANW.L Regulatory News (ANW)

  • There is currently no data for ANW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

1 Sep 2017 14:40

RNS Number : 6260P
Aberdeen New Thai Inv Trust PLC
01 September 2017
 

ABERDEEN NEW THAI INVESTMENT TRUST PLC

Legal Entity Identifier (LEI): 213800LUTHTZ8LS5UK85

Information disclosed in accordance with DTR 5.1, 5.3 and 5.8

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Aberdeen New Thai Investment Trust PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Lazard Asset Management LLC

City and country of registered office (if applicable)

New York, United States of America

4. Full name of shareholder(s) (if different from 3.)v

Name

Bank of New York, Inc. - Dir Personal

Bank of New York, Inc. - Global Custody

J.P. Morgan Chase - SWIFT

Northern Trust Co

State Street Bank- Master Tr - ETC

State Street Bank-Custody Master Trust

 

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

31 August 2017

6. Date on which issuer notified (DD/MM/YYYY):

01/09/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

20.967%

N/A

20.967%

18,025,032

Position of previous notification (if

applicable)

21.098%

N/A

21.098%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0004543517

3,779,303

20.967%

SUBTOTAL 8. A

3,779,303

20.967%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lazard Asset Management LLC

20.967%

20.967%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Contact name: Stuart Reid, Aberdeen Asset Management PLC, SECRETARY

Contact telephone number: 0131 528 4000

 

Place of completion

Lazard Asset Management Limited

Date of completion

01 September 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAOORBKAKRAR
Date   Source Headline
2nd Oct 202012:32 pmRNSNet Asset Value(s)
1st Oct 20209:57 amRNSTotal Voting Rights
30th Sep 202011:49 amRNSNet Asset Value(s)
29th Sep 202012:28 pmRNSNet Asset Value(s)
28th Sep 20202:36 pmRNSGearing disclosure
28th Sep 202012:10 pmRNSNet Asset Value(s)
25th Sep 20201:52 pmRNSNet Asset Value(s)
24th Sep 202012:13 pmRNSNet Asset Value(s)
23rd Sep 202012:18 pmRNSNet Asset Value(s)
22nd Sep 202012:38 pmRNSNet Asset Value(s)
21st Sep 20201:42 pmRNSGearing disclosure
21st Sep 202012:40 pmRNSNet Asset Value(s)
18th Sep 202011:36 amRNSNet Asset Value(s)
17th Sep 202011:44 amRNSNet Asset Value(s)
16th Sep 20205:05 pmRNSTransaction in Own Shares
16th Sep 202011:53 amRNSNet Asset Value(s)
15th Sep 202011:58 amRNSNet Asset Value(s)
14th Sep 202012:37 pmRNSGearing disclosure
14th Sep 202012:22 pmRNSNet Asset Value(s)
11th Sep 202011:57 amRNSPortfolio disclosures
11th Sep 202011:14 amRNSNet Asset Value(s)
10th Sep 202011:50 amRNSNet Asset Value(s)
9th Sep 202011:23 amRNSNet Asset Value(s)
8th Sep 202011:47 amRNSNet Asset Value(s)
8th Sep 20207:00 amRNSCompliance with Market Abuse Regulation
7th Sep 20201:24 pmRNSGearing Disclosure
7th Sep 202012:01 pmRNSNet Asset Value(s)
4th Sep 20201:50 pmRNSMonth End Net Asset Value(s)
4th Sep 202011:11 amRNSNet Asset Value(s)
3rd Sep 202011:28 amRNSNet Asset Value(s)
2nd Sep 20201:08 pmRNSQuarterly Disclosures
2nd Sep 202011:53 amRNSNet Asset Value(s)
1st Sep 20205:05 pmRNSTransaction in Own Shares
1st Sep 20204:03 pmRNSGearing Disclosure
1st Sep 20202:39 pmRNSNet Asset Value(s)
1st Sep 20208:42 amRNSTotal Voting Rights
28th Aug 20205:11 pmRNSTransaction in Own Shares
28th Aug 202011:33 amRNSNet Asset Value(s)
27th Aug 202012:40 pmRNSNet Asset Value(s)
26th Aug 202012:49 pmRNSNet Asset Value(s)
25th Aug 202011:44 amRNSNet Asset Value(s)
24th Aug 202012:05 pmRNSNet Asset Value(s)
21st Aug 202011:39 amRNSNet Asset Value(s)
20th Aug 20203:03 pmRNSHolding(s) in Company
20th Aug 202012:31 pmRNSNet Asset Value(s)
19th Aug 202012:48 pmRNSNet Asset Value(s)
18th Aug 20205:06 pmRNSTransaction in Own Shares
18th Aug 202011:42 amRNSNet Asset Value(s)
17th Aug 20204:46 pmRNSGearing Disclosures
17th Aug 202012:18 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.